z-logo
Premium
Relation of troponin T release kinetics to long‐term clinical outcome in patients with acute ST segment elevation myocardial infarction treated with a percutaneous intervention
Author(s) -
Karavidas Apostolos J.,
Vrachatis Antony D.,
Alpert Martin A.,
Nikas Dimitris J.,
Achtypis Dionissios I.,
Masrakas Evagellas P.,
Foukarakis Masolis G.,
Fotiades Toannis N.,
Zacharoulis Apostolos A.
Publication year - 2002
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.10229
Subject(s) - medicine , percutaneous coronary intervention , cardiology , myocardial infarction , troponin , troponin i , st segment , killip class , troponin t , angioplasty , chest pain
The purpose of this study was to determine the relation of troponin T release kinetics to long‐term clinical outcome in patients with an acute ST segment elevation myocardial infarction treated with a primary percutaneous intervention. One hundred and four patients with typical ischemic chest pain and > 1.5 mm ST segment elevation in > 2 contiguous leads underwent primary stenting (n = 60) or primary percutaneous transluminal coronary angioplasty (n = 44). Serum troponin T concentrations were obtained prior to and serially postintervention for 72 hr. Mean time to peak serum troponin T concentration was significantly longer in patients with cardiac death ( P = 0.02), reinfarction ( P = 0.007), target lesion reintervention ( P = 0.03), and the composite of these events (13.2 ± 5.3 vs. 9.3 ± 4.0 hr; P < 0.0005). Multivariate analysis identified age, Killip class > 2, and time to peak serum troponin T concentration as independent predictors of long‐term cardiac event‐free survival. Thus, time to peak serum troponin T concentration independently predicts long‐term cardiac event‐free survival in patients with acute ST segment elevation myocardial infarction treated with a primary percutaneous intervention. Cathet Cardiovasc Intervent 2002;56:312–319. © 2002 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom